Regulus Therapeutics Inc (NASDAQ:RGLS)

16.82
Delayed Data
As of Mar 27
 +0.26 / +1.57%
Today’s Change
5.40
Today|||52-Week Range
25.60
+4.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues1.6M736.0K1.1M4.2M
 
 
 
 
 
Depreciation And Amortization354.0K346.0K398.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.0M13.4M12.3M13.8M
 
 
 
 
 
Research And Development9.6M10.8M10.2M10.5M
 
 
 
 
 
Total Operating Expenses12.3M13.7M12.7M13.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-13.0M-11.7M-9.5M
 
 
 
 
 
Extraordinary Credit0.00953.0K1.8M--
 
 
 
Extraordinary Charge-2.1M0.00---12.7M
 
 
 
Interest Expense On Debt11.0K10.0K10.0K--
 
 
 
 
Other Expenses0.000.000.0065.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.7M-12.0M-9.8M-22.2M
 
 
 
 
 
Income Taxes-1.0K0.000.000.00
 
 
Net Income-12.7M-12.0M-9.8M-22.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.7M43.4M43.4M46.9M
 
 
 
 
 
Shares To Calculate EPS Diluted42.7M44.8M43.4M46.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$0.29-$0.23-$0.47
 
 
 
 
 
EPS Diluted-$0.30-$0.29-$0.23-$0.47
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account